DE2802281A1 - Neue phenylen-bis-diketone, ihre herstellung und deren verwendung - Google Patents
Neue phenylen-bis-diketone, ihre herstellung und deren verwendungInfo
- Publication number
- DE2802281A1 DE2802281A1 DE19782802281 DE2802281A DE2802281A1 DE 2802281 A1 DE2802281 A1 DE 2802281A1 DE 19782802281 DE19782802281 DE 19782802281 DE 2802281 A DE2802281 A DE 2802281A DE 2802281 A1 DE2802281 A1 DE 2802281A1
- Authority
- DE
- Germany
- Prior art keywords
- bis
- benzene
- hal
- heptanedione
- hai
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000004519 manufacturing process Methods 0.000 title description 4
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical class CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 title 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 51
- 150000001875 compounds Chemical class 0.000 claims description 24
- -1 alkali metal salt Chemical class 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 13
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 7
- 239000002585 base Substances 0.000 claims description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052794 bromium Inorganic materials 0.000 claims description 7
- 239000003960 organic solvent Substances 0.000 claims description 7
- 229910052783 alkali metal Inorganic materials 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 241000700605 Viruses Species 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 229910052740 iodine Inorganic materials 0.000 claims description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 4
- 239000013522 chelant Substances 0.000 claims description 4
- 125000005594 diketone group Chemical group 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 229910001385 heavy metal Inorganic materials 0.000 claims description 4
- 239000011630 iodine Substances 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 239000007789 gas Substances 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- IQHSSYROJYPFDV-UHFFFAOYSA-N 2-bromo-1,3-dichloro-5-(trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC(Cl)=C(Br)C(Cl)=C1 IQHSSYROJYPFDV-UHFFFAOYSA-N 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 10
- 238000000338 in vitro Methods 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- DGCTVLNZTFDPDJ-UHFFFAOYSA-N heptane-3,5-dione Chemical compound CCC(=O)CC(=O)CC DGCTVLNZTFDPDJ-UHFFFAOYSA-N 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241001529453 unidentified herpesvirus Species 0.000 description 6
- 125000001989 1,3-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([H])C([*:2])=C1[H] 0.000 description 5
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 230000009897 systematic effect Effects 0.000 description 5
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 4
- 238000010189 synthetic method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ULTHEAFYOOPTTB-UHFFFAOYSA-N 1,4-dibromobutane Chemical compound BrCCCCBr ULTHEAFYOOPTTB-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CNPIVEYAEOWQKB-UHFFFAOYSA-N 4-(3-bromopropoxy)phenol Chemical compound OC1=CC=C(OCCCBr)C=C1 CNPIVEYAEOWQKB-UHFFFAOYSA-N 0.000 description 3
- SWCLWBXALDRKEJ-UHFFFAOYSA-N 4-(6-bromohexyl)heptane-3,5-dione Chemical compound CCC(=O)C(C(=O)CC)CCCCCCBr SWCLWBXALDRKEJ-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 229940117389 dichlorobenzene Drugs 0.000 description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 3
- SIAPCJWMELPYOE-UHFFFAOYSA-N lithium hydride Chemical compound [LiH] SIAPCJWMELPYOE-UHFFFAOYSA-N 0.000 description 3
- 229910000103 lithium hydride Inorganic materials 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- SGRHVVLXEBNBDV-UHFFFAOYSA-N 1,6-dibromohexane Chemical compound BrCCCCCCBr SGRHVVLXEBNBDV-UHFFFAOYSA-N 0.000 description 2
- GUUVKHVLGXQUIL-UHFFFAOYSA-N 1-(4-bromobutoxy)-4-(3-bromopropoxy)benzene Chemical compound BrCCCCOC1=CC=C(OCCCBr)C=C1 GUUVKHVLGXQUIL-UHFFFAOYSA-N 0.000 description 2
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 2
- VJIDDJAKLVOBSE-UHFFFAOYSA-N 2-ethylbenzene-1,4-diol Chemical compound CCC1=CC(O)=CC=C1O VJIDDJAKLVOBSE-UHFFFAOYSA-N 0.000 description 2
- NJJZGESBXYGFLJ-UHFFFAOYSA-N 3-(6-bromohexyl)pentane-2,4-dione Chemical compound CC(=O)C(C(C)=O)CCCCCCBr NJJZGESBXYGFLJ-UHFFFAOYSA-N 0.000 description 2
- MEQWGZBVNBGKCD-UHFFFAOYSA-N 4-[2-(bromomethyl)butyl]heptane-3,5-dione Chemical compound CCC(CBr)CC(C(=O)CC)C(=O)CC MEQWGZBVNBGKCD-UHFFFAOYSA-N 0.000 description 2
- XMLCWRROGNYLHY-UHFFFAOYSA-N 6-(6-bromohexyl)undecane-5,7-dione Chemical compound CCCCC(=O)C(C(=O)CCCC)CCCCCCBr XMLCWRROGNYLHY-UHFFFAOYSA-N 0.000 description 2
- 229930185605 Bisphenol Natural products 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 101150065749 Churc1 gene Proteins 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102100038239 Protein Churchill Human genes 0.000 description 2
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Substances ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- AJPXTSMULZANCB-UHFFFAOYSA-N chlorohydroquinone Chemical compound OC1=CC=C(O)C(Cl)=C1 AJPXTSMULZANCB-UHFFFAOYSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 229910003002 lithium salt Inorganic materials 0.000 description 2
- 159000000002 lithium salts Chemical class 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- CNHDIAIOKMXOLK-UHFFFAOYSA-N toluquinol Chemical compound CC1=CC(O)=CC=C1O CNHDIAIOKMXOLK-UHFFFAOYSA-N 0.000 description 2
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 description 1
- KTOGCLNNHBUUOX-UHFFFAOYSA-N 1,4-bis(4-bromobutoxy)benzene Chemical compound BrCCCCOC1=CC=C(OCCCCBr)C=C1 KTOGCLNNHBUUOX-UHFFFAOYSA-N 0.000 description 1
- QIGWMDCDKHTWLP-UHFFFAOYSA-N 1,5-dibromo-2,4-dimethylpentane Chemical compound BrCC(C)CC(C)CBr QIGWMDCDKHTWLP-UHFFFAOYSA-N 0.000 description 1
- XFGAIQYQWGRYSL-UHFFFAOYSA-N 1-bromo-2-(bromomethyl)butane Chemical compound CCC(CBr)CBr XFGAIQYQWGRYSL-UHFFFAOYSA-N 0.000 description 1
- YRAJNWYBUCUFBD-UHFFFAOYSA-N 2,2,6,6-tetramethylheptane-3,5-dione Chemical compound CC(C)(C)C(=O)CC(=O)C(C)(C)C YRAJNWYBUCUFBD-UHFFFAOYSA-N 0.000 description 1
- FJPGAMCQJNLTJC-UHFFFAOYSA-N 2,3-Heptanedione Chemical compound CCCCC(=O)C(C)=O FJPGAMCQJNLTJC-UHFFFAOYSA-N 0.000 description 1
- AYNPIRVEWMUJDE-UHFFFAOYSA-N 2,5-dichlorohydroquinone Chemical compound OC1=CC(Cl)=C(O)C=C1Cl AYNPIRVEWMUJDE-UHFFFAOYSA-N 0.000 description 1
- 125000005826 2-chloro-1,4-phenylene group Chemical group [H]C1=C([*:2])C([H])=C(Cl)C([*:1])=C1[H] 0.000 description 1
- HPLUXOMGUZEHFT-UHFFFAOYSA-N 2-iodobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(I)=C1 HPLUXOMGUZEHFT-UHFFFAOYSA-N 0.000 description 1
- USUCLCAKPNCNIH-UHFFFAOYSA-N 4-(5-bromo-2,4-dimethylpentyl)heptane-3,5-dione Chemical compound CCC(=O)C(C(=O)CC)CC(C)CC(C)CBr USUCLCAKPNCNIH-UHFFFAOYSA-N 0.000 description 1
- XACHTKBRCOBJNC-UHFFFAOYSA-N 4-(6-bromohexyl)-2,2,6,6-tetramethylheptane-3,5-dione Chemical compound CC(C)(C)C(=O)C(C(=O)C(C)(C)C)CCCCCCBr XACHTKBRCOBJNC-UHFFFAOYSA-N 0.000 description 1
- VSQKUJFSQAYHHC-UHFFFAOYSA-N 4-(7-bromoheptyl)heptane-3,5-dione Chemical compound CCC(=O)C(C(=O)CC)CCCCCCCBr VSQKUJFSQAYHHC-UHFFFAOYSA-N 0.000 description 1
- DLUBNXABZGPVPK-UHFFFAOYSA-N 4-[4-[4-(6-oxo-5-propanoyloctoxy)phenoxy]butyl]heptane-3,5-dione Chemical compound CCC(=O)C(C(=O)CC)CCCCOC1=CC=C(OCCCCC(C(=O)CC)C(=O)CC)C=C1 DLUBNXABZGPVPK-UHFFFAOYSA-N 0.000 description 1
- ZHMUEOZXOKOLOJ-UHFFFAOYSA-N 4-[5-[4-(7-oxo-6-propanoylnonoxy)phenoxy]pentyl]heptane-3,5-dione Chemical compound CCC(=O)C(C(=O)CC)CCCCCOC1=CC=C(OCCCCCC(C(=O)CC)C(=O)CC)C=C1 ZHMUEOZXOKOLOJ-UHFFFAOYSA-N 0.000 description 1
- HROIEFVHUAKWFL-UHFFFAOYSA-N 4-[6-[3-(8-oxo-7-propanoyldecoxy)phenoxy]hexyl]heptane-3,5-dione Chemical compound CCC(=O)C(C(=O)CC)CCCCCCOC1=CC=CC(OCCCCCCC(C(=O)CC)C(=O)CC)=C1 HROIEFVHUAKWFL-UHFFFAOYSA-N 0.000 description 1
- ZMMZUOQSCFSZFG-UHFFFAOYSA-N 4-[6-[3-[7-(2,2-dimethylpropanoyl)-9,9-dimethyl-8-oxodecoxy]phenoxy]hexyl]-2,2,6,6-tetramethylheptane-3,5-dione Chemical compound CC(C)(C)C(=O)C(C(=O)C(C)(C)C)CCCCCCOC1=CC=CC(OCCCCCCC(C(=O)C(C)(C)C)C(=O)C(C)(C)C)=C1 ZMMZUOQSCFSZFG-UHFFFAOYSA-N 0.000 description 1
- IFMKHEAORKALDJ-UHFFFAOYSA-N 4-[6-[3-chloro-4-(8-oxo-7-propanoyldecoxy)phenoxy]hexyl]heptane-3,5-dione Chemical compound CCC(=O)C(C(=O)CC)CCCCCCOC1=CC=C(OCCCCCCC(C(=O)CC)C(=O)CC)C(Cl)=C1 IFMKHEAORKALDJ-UHFFFAOYSA-N 0.000 description 1
- FGKQCQPXVJSEFQ-UHFFFAOYSA-N 4-[6-[3-ethyl-4-(8-oxo-7-propanoyldecoxy)phenoxy]hexyl]heptane-3,5-dione Chemical compound CCC(=O)C(C(=O)CC)CCCCCCOC1=CC=C(OCCCCCCC(C(=O)CC)C(=O)CC)C(CC)=C1 FGKQCQPXVJSEFQ-UHFFFAOYSA-N 0.000 description 1
- OUVYEIREXUBORS-UHFFFAOYSA-N 4-[6-[3-methyl-4-(8-oxo-7-propanoyldecoxy)phenoxy]hexyl]heptane-3,5-dione Chemical compound CCC(=O)C(C(=O)CC)CCCCCCOC1=CC=C(OCCCCCCC(C(=O)CC)C(=O)CC)C(C)=C1 OUVYEIREXUBORS-UHFFFAOYSA-N 0.000 description 1
- DBAXZDKFXBCOBA-UHFFFAOYSA-N 4-[6-[4-(8-oxo-7-propanoyldecoxy)phenoxy]hexyl]heptane-3,5-dione Chemical compound CCC(=O)C(C(=O)CC)CCCCCCOC1=CC=C(OCCCCCCC(C(=O)CC)C(=O)CC)C=C1 DBAXZDKFXBCOBA-UHFFFAOYSA-N 0.000 description 1
- STKWFNNBBPHWSR-UHFFFAOYSA-N 4-[7-[4-(9-oxo-8-propanoylundecoxy)phenoxy]heptyl]heptane-3,5-dione Chemical compound CCC(=O)C(C(=O)CC)CCCCCCCOC1=CC=C(OCCCCCCCC(C(=O)CC)C(=O)CC)C=C1 STKWFNNBBPHWSR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- ZULJYVVAYGFYKU-UHFFFAOYSA-N acetonitrile;chloroform Chemical compound CC#N.ClC(Cl)Cl ZULJYVVAYGFYKU-UHFFFAOYSA-N 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- YCOXTKKNXUZSKD-UHFFFAOYSA-N as-o-xylenol Natural products CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000012925 biological evaluation Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- QKGYJVXSKCDGOK-UHFFFAOYSA-N hexane;propan-2-ol Chemical compound CC(C)O.CCCCCC QKGYJVXSKCDGOK-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000003541 multi-stage reaction Methods 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/761,944 US4096280A (en) | 1977-01-24 | 1977-01-24 | Arylenedioxy-bis-diketones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2802281A1 true DE2802281A1 (de) | 1978-07-27 |
Family
ID=25063682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19782802281 Withdrawn DE2802281A1 (de) | 1977-01-24 | 1978-01-19 | Neue phenylen-bis-diketone, ihre herstellung und deren verwendung |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4096280A (en, 2012) |
| JP (1) | JPS53101319A (en, 2012) |
| AU (1) | AU516354B2 (en, 2012) |
| BE (1) | BE863007A (en, 2012) |
| CA (1) | CA1084065A (en, 2012) |
| CH (1) | CH629741A5 (en, 2012) |
| DE (1) | DE2802281A1 (en, 2012) |
| DK (1) | DK25178A (en, 2012) |
| FR (1) | FR2377993A1 (en, 2012) |
| GB (1) | GB1561672A (en, 2012) |
| IE (1) | IE46495B1 (en, 2012) |
| LU (1) | LU78914A1 (en, 2012) |
| NL (1) | NL7800668A (en, 2012) |
| NZ (1) | NZ186219A (en, 2012) |
| SE (1) | SE7800621L (en, 2012) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0068250A1 (de) * | 1981-06-26 | 1983-01-05 | Bayer Ag | Dioxybenzoletherderivate, diese enthaltende Arzneimittel, Verfahren zu ihrer Herstellung und ihre Verwendung |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4208425A (en) * | 1977-09-06 | 1980-06-17 | Sterling Drug Inc. | Novel diketones |
| US4372976A (en) * | 1981-08-07 | 1983-02-08 | Sterling Drug Inc. | Novel aryl-aliphatic ketone and its use as an antiviral agent |
| IL91382A (en) * | 1988-09-01 | 1995-06-29 | Orion Yhtymae Oy | Alkenyl or arylmethylene-substituted beta-diketones their preparation and pharmaceutical compositions containing them |
| US5185370A (en) * | 1988-09-01 | 1993-02-09 | Orion-Yhtyma Oy | Substituted β-diketones and their use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3721704A (en) * | 1967-02-17 | 1973-03-20 | Geigy Chem Corp | Esters of (dialkyl-4-hydroxy-phenyl)malonic acid and related compounds |
| US3541155A (en) * | 1968-05-16 | 1970-11-17 | Monsanto Co | Phenoxypentanediones |
| US3917718A (en) * | 1972-06-22 | 1975-11-04 | Sterling Drug Inc | Cyclopropyl carbinol derivatives |
| US3933837A (en) * | 1973-07-23 | 1976-01-20 | Sterling Drug Inc. | 3,4-Methylenedioxyphenoxy-alkyl diketones and keto-esters |
| US4031246A (en) * | 1973-07-23 | 1977-06-21 | Sterling Drug Inc. | Aryloxyalkyl diketones |
-
1977
- 1977-01-24 US US05/761,944 patent/US4096280A/en not_active Expired - Lifetime
-
1978
- 1978-01-03 IE IE8/78A patent/IE46495B1/en unknown
- 1978-01-09 GB GB735/78A patent/GB1561672A/en not_active Expired
- 1978-01-13 NZ NZ186219A patent/NZ186219A/xx unknown
- 1978-01-16 AU AU32468/78A patent/AU516354B2/en not_active Expired
- 1978-01-17 FR FR7801263A patent/FR2377993A1/fr active Granted
- 1978-01-18 CH CH53678A patent/CH629741A5/fr not_active IP Right Cessation
- 1978-01-18 BE BE1008651A patent/BE863007A/xx unknown
- 1978-01-18 CA CA295,226A patent/CA1084065A/en not_active Expired
- 1978-01-18 SE SE7800621A patent/SE7800621L/xx unknown
- 1978-01-18 DK DK25178A patent/DK25178A/da not_active Application Discontinuation
- 1978-01-19 JP JP476078A patent/JPS53101319A/ja active Pending
- 1978-01-19 DE DE19782802281 patent/DE2802281A1/de not_active Withdrawn
- 1978-01-19 LU LU78914A patent/LU78914A1/xx unknown
- 1978-01-19 NL NL7800668A patent/NL7800668A/xx not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0068250A1 (de) * | 1981-06-26 | 1983-01-05 | Bayer Ag | Dioxybenzoletherderivate, diese enthaltende Arzneimittel, Verfahren zu ihrer Herstellung und ihre Verwendung |
Also Published As
| Publication number | Publication date |
|---|---|
| NL7800668A (nl) | 1978-07-26 |
| JPS53101319A (en) | 1978-09-04 |
| SE7800621L (sv) | 1978-07-25 |
| DK25178A (da) | 1978-07-25 |
| FR2377993B1 (en, 2012) | 1980-07-04 |
| NZ186219A (en) | 1979-04-26 |
| GB1561672A (en) | 1980-02-27 |
| US4096280A (en) | 1978-06-20 |
| AU516354B2 (en) | 1981-05-28 |
| IE46495B1 (en) | 1983-06-29 |
| CA1084065A (en) | 1980-08-19 |
| LU78914A1 (fr) | 1978-09-28 |
| AU3246878A (en) | 1979-07-26 |
| BE863007A (fr) | 1978-07-18 |
| IE780008L (en) | 1978-07-24 |
| FR2377993A1 (fr) | 1978-08-18 |
| CH629741A5 (fr) | 1982-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2925113C2 (en, 2012) | ||
| EP0116323A1 (de) | Verfahren zur Herstellung von aromatischen Aldehyden | |
| DE2802281A1 (de) | Neue phenylen-bis-diketone, ihre herstellung und deren verwendung | |
| US4014940A (en) | Process for preparing m-phenoxybenzylalcohol and side-chain halogenated m-phenoxytoluene | |
| DE2543870A1 (de) | Verfahren zur herstellung von 5-fluor-2-methyl-1-(p-methyl-sulfinylbenzyliden)-indenyl-3-essigsaeure | |
| EP0144044B1 (de) | Substituierte Acetylenketone | |
| DE2548970C3 (de) | Verfahren zur Herstellung von Trichlormethyl-trifluormethyl-benzolen | |
| DE2656545A1 (de) | Polyhalogenierte alpha, alpha'-difluordialkylaether und verfahren zu ihrer herstellung | |
| DE2729846C2 (de) | Verfahren zur Herstellung von in 3-Stellung alkylsubstituierten cis-1-Hydroxy-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo [b,d] pyran-9-onen | |
| EP0055427B1 (de) | Verfahren zur Herstellung von Monochlormethylketonen | |
| US4208425A (en) | Novel diketones | |
| US3933837A (en) | 3,4-Methylenedioxyphenoxy-alkyl diketones and keto-esters | |
| EP0095047A1 (de) | Verfahren zur Herstellung von 3-vinylsubstituierten 2,2-Dimethylcyclopropan-1-carbonsäuren bzw. ihren Estern und neue Zwischenprodukte dafür | |
| DD254733A5 (de) | Verfahren zur herstellung von phenoxyalkanoltriazolverbindungen | |
| DE3021516C2 (en, 2012) | ||
| DE2838276A1 (de) | Beta -substituierte diketone, verfahren zu deren herstellung und diese enthaltende arzneimittel | |
| EP0131130B1 (de) | Verfahren zur Herstellung von Cycloalkenylalkinen | |
| US4171371A (en) | Diketones | |
| EP0374554B1 (de) | Chirale Verbindungen vom beta-Binaphthyltyp, deren Herstellung und deren Verwendung | |
| EP0290903B1 (de) | Beta-Fluoracyl-beta-halogenvinylalkylether | |
| EP0037062B1 (de) | Substituierte 3-Aryl-2-cycloalken-1-one, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| DE2821540C2 (en, 2012) | ||
| DE2642415A1 (de) | Syntheseverfahren fuer in 6-stellung substituierte 2,3-dimethoxy-5-methyl-1,4- benzochinone | |
| AT346307B (de) | Verfahren zur herstellung neuer aryloxyalkyl- diketone | |
| DE3725941A1 (de) | Ester von arylperfluoralkylcarbinolen, verfahren zur herstellung dieser verbindungen und der zugrundeliegenden arylbisperfluoralkylcarbinole |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8139 | Disposal/non-payment of the annual fee |